Fractals: Life Science Conversations

The Radiopharmaceutical “Unk-Unk”: Managing Pharmaceutical Strategy and Logistics with Guest Andrew Beck

Episode Notes

Andrew Beck’s impressive career has spanned various niches across the radiopharmaceutical development sphere. From utilizing a holistic path for building a successful strategy to the key pairing of pharmaceutical sales and patient advocacy, Andrew understands that an integrated approach is paramount to success. On this episode of Fractals: The Life Sciences Questionnaire, dig deeper into radiopharmaceutical development and hear Andrew’s key insights on:

• What the radiopharmaceutical “unk-unk” is (and how to navigate running into associated roadblocks),
• Why the simple availability of a product doesn’t necessarily indicate adoption of treatment,
• How beginning with the end in mind is key critical to building a holistic and successful business and/or commercialization strategy, 
• Why and how patient advocacy will continue to advance both standard of care and collaborative business strategy.